Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v15-EN | Version v15-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2025-09-10 | 2025-09-10 |
| Drug Identification Number | 02469405 | 02469405 |
| Brand name | PREVYMIS | PREVYMIS |
| Common or Proper name | Letermovir for injection | Letermovir for injection |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | LETERMOVIR | LETERMOVIR |
| Strength(s) | 20MG | 20MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 480mg vial | 480mg vial |
| ATC code | J05AX | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2025-09-30 | 2025-09-30 |
| Actual discontinuation date | 2025-09-09 | 2025-09-09 |
| Remaining supply date | 2025-09-09 | 2025-09-09 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | PREVYMIS® injection supplied in single-dose vials at a concentration of 20mg/mL remains available in the 240 mg presentation (DIN 02469367). | PREVYMIS® injection supplied in single-dose vials at a concentration of 20mg/mL remains available in the 240 mg presentation (DIN 02469367). |
| Health Canada comments |